Rxo (RXO) Depreciation & Amortization (CF) (2021 - 2026)

Rxo (RXO) has 6 years of Depreciation & Amortization (CF) data on file, last reported at $26.0 million in Q1 2026.

• Quarterly Depreciation & Amortization (CF) fell 18.75% year-over-year to $26.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $110.0 million (up 6.8% YoY) and the FY2025 annual result came in at $116.0 million, up 33.33% from the prior year.
• Depreciation & Amortization (CF) declined to $26.0 million in Q1 2026, from $28.0 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $33.0 million in Q4 2024 to a low of $15.0 million in Q4 2023.
• A 5-year average of $22.5 million and a median of $21.0 million in 2022 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) slumped 30.43% — and 2024, when it soared 120.0%.
• Tracing RXO's Depreciation & Amortization (CF) over 5 years: stood at $21.0 million in 2022, then retreated by 28.57% to $15.0 million in 2023, then jumped by 120.0% to $33.0 million in 2024, then declined by 15.15% to $28.0 million in 2025, then retreated by 7.14% to $26.0 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $26.0 million (Q1 2026), $28.0 million (Q4 2025), and $26.0 million (Q3 2025), per Business Quant data.